Bioclinical Systems, Inc.

Bioclinical Systems, Inc. — FDA 510(k) Submissions

Bioclinical Systems, Inc. has submitted 13 FDA 510(k) premarket notifications since 1985, of which 13 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Culture Media, For Isolation Of Pathogenic Neisseria, Radioimmunoassay, Luteinizing Hormone, Glucose Oxidase, Glucose, Tetraphenyl Borate, Colorimetry, Potassium, Visual, Pregnancy Hcg, Prescription Use . Use the specialty filter in the sidebar to narrow results.